Canopy Growth to supply four cannabis strains to UK market
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures drop over 1% as AI worries resurface, oil climbs
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Canopy Growth Expands European Medical Cannabis Supply Into the UK
September 22, 2026 7:30 AM EDTFour Canadian-grown flower strains to be supplied for distribution in the UK medical cannabis market under Spectrum Therapeutics
SMITHS FALLS, Ontario--(BUSINESS WIRE)-- Canopy Growth Corporation (Canopy Growth, our, we or the Company) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that it will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom (the UK), expanding the reach of its international cannabis business into another European market.
The Canadian-grown flower strains will be... More



